# Shanghai Miaoyi Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-miaoyi-biotechnology-co

- Industry: Healthcare IT
- Headquarters: Shanghai, China
- Website: www.yaoyanshe.com
- Total disclosed funding: $86M
- Latest round: Series D (Aug 10, 2020)
- Investors on record: 6

## About

Founded in 2015 and based in Shanghai, China, Shanghai Miaoyi Biotechnology Co., Ltd. operates as a developer of  artificial intelligence-based mobile application for the pharmaceutical research industry.

## Funding rounds

- Series D, Aug 10, 2020, $43M — Eastern Bell Capital, Vision Plus Capital, MPC, Jiyuan Capital
- Series C, Aug 16, 2019, $43M — Hong Shan, Eastern Bell Capital, Genesis Capital, Vision Plus Capital, MPC
- Series B, Nov 19, 2018 — Genesis Capital
- Series A, Jun 13, 2018 — Vision Plus Capital, MPC

## Investors

- Vision Plus Capital (https://capitalatlas.ai/funds/vision-plus-capital) — Series A, Series C, Series D
- MPC — Series A, Series C, Series D
- Genesis Capital — Series B, Series C
- Hong Shan — Series C
- Eastern Bell Capital — Series C, Series D
- Jiyuan Capital (https://capitalatlas.ai/funds/jiyuan-capital) — Series D
